reference/8608482

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8608482

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	4711
issn	1476-5594 0950-9232
issueIdentifier	34
pageRange	4702-4711
publicationName	Oncogene
startingPage	4702
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bc1750c08713c2947ae5367bc27ca73a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8990eaf11b469f43462c30ceeb3fad6a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_95b73d2e09d1c1e33012969a24c96de4 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2673a660224b91e5d6ddc621b1806a59 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b29a0e992718c654c2b61566786f82e3 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_45801848a25cad48360a7784778f500a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_91146b65d3ad5bcd1efacff289863c79 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d85b8ab866b7bbb8372b2e7de8b867ad http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7424bd70bf2a5f617695474e5ee04888 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5628bcb29ea1df5206c616f8b35203df http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cdf9830b8041b0ce20f53e1365571932 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c4e332468261a8edd2da3a11bda96656
bibliographicCitation	Li D, Ambrogio L, Shimamura T, Kubo S, Takahashi M, Chirieac LR, Padera RF, Shapiro GI, Baum A, Himmelsbach F, Rettig WJ, Meyerson M, Solca F, Greulich H, Wong KK. BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models. Oncogene. 2008 Aug 07;27(34):4702–11. PMID: 18408761; PMCID: PMC2748240.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1861aadaa2dc3def4bd4c86b633ca4e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5483922047a835d1b10d318bba5b2b93 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3970156ec3cfdb543d8d098a21c1a83 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_986be6c851d268e0f9ab779ed13ab81f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a44b155ef458bc080045b6dd90f847bd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a4995e7a9425b8945d2cbc24f857b7d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_030b5188a9304a47fafbb4fd0ec4e3f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3048106702e788ba53b2e588f6884fc1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_85442817e3816434b80e2870ed0ed0f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b88b28d564f282e62e2b09a1818a41e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82f871de33f470a8697f3c0dfa34fa8f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_159aef0a4c041f1b2d9345204f0c48d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b09f02078219b793aec87248de830e7e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c06f18f870ab55361475514b108ecfa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b78773c9cd47321f5dde85763e5edce1
date	2008-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC2748240 https://pubmed.ncbi.nlm.nih.gov/18408761 https://doi.org/10.1038/onc.2008.109
isPartOf	https://portal.issn.org/resource/ISSN/0950-9232 https://portal.issn.org/resource/ISSN/1476-5594 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6325
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
discusses	http://id.nlm.nih.gov/mesh/M0028048 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0561143 http://id.nlm.nih.gov/mesh/M0500817 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0018336
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112 http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6650 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d7d07219eb0333b77b9c1ec30e7594d4 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10184653 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_79ad58d09e4d39d7b6c4574fc8a98844 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12413939 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
citesAsDataSource	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID178102295_AID1345653_PMID18408761_VALUE15 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID178102295_AID1345502_PMID18408761_VALUE45
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127407363 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127377427 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1956 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2064 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID178102295

Total number of triples: 80.